These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 18321672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G, Abu-Alfa A.
    Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK, Thomsen HS.
    Nephron Clin Pract; 2008 May; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [Abstract] [Full Text] [Related]

  • 5. MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May; 66(2):153-9. PubMed ID: 18343071
    [Abstract] [Full Text] [Related]

  • 6. Extracellular Gd-CA: differences in prevalence of NSF.
    Thomsen HS, Marckmann P.
    Eur J Radiol; 2008 May; 66(2):180-3. PubMed ID: 18342468
    [Abstract] [Full Text] [Related]

  • 7. Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk.
    Nicholas BA, Vricella GJ, Smith M, Passalacqua M, Gulani V, Ponsky LE.
    Can J Urol; 2012 Feb; 19(1):6074-80. PubMed ID: 22316507
    [Abstract] [Full Text] [Related]

  • 8. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis and management of high-risk patients.
    Altun E, Semelka RC, Cakit C.
    Acad Radiol; 2009 Jul; 16(7):897-905. PubMed ID: 19375360
    [Abstract] [Full Text] [Related]

  • 10. MRI gadolinium-based contrast agents. Radiologists beware!
    Goullé JP, Cattanéo A, Saussereau E, Mahieu L, Guerbet M, Lacroix C.
    Ann Pharm Fr; 2009 Sep; 67(5):335-9. PubMed ID: 19695369
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance angiography (MRA) in renally impaired patients: when and how.
    Bongartz G, Mayr M, Bilecen D.
    Eur J Radiol; 2008 May; 66(2):213-9. PubMed ID: 18329834
    [Abstract] [Full Text] [Related]

  • 12. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 13. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 14. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A.
    J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Peak AS, Sheller A.
    Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
    [Abstract] [Full Text] [Related]

  • 16. [Nephrogenic systemic fibrosis].
    Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A.
    G Ital Nefrol; 2008 Sep; 25(1):14-20. PubMed ID: 18264914
    [Abstract] [Full Text] [Related]

  • 17. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 18. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
    Abraham JL, Thakral C.
    Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
    [Abstract] [Full Text] [Related]

  • 19. Extracellular gadolinium-based contrast media: an overview.
    Bellin MF, Van Der Molen AJ.
    Eur J Radiol; 2008 May; 66(2):160-7. PubMed ID: 18358659
    [Abstract] [Full Text] [Related]

  • 20. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.